Blog
Clinical trial data sources bound to increase and diversify
It should come as no surprise that the volume and diversity of clinical trial data is expected to rapidly increase over the next few years. The proliferation of mobile health tech, real world evidence (RWE), electronic data capture (EDC) systems, etc. in...
FDA issues draft guidance that would clarify and extend ICH E9 guideline on clinical trial analyses
The U.S. Food and Drug Administration (FDA) issued a draft guidance suggesting the agency adopt an International Council for Harmonization (ICH) to a 1998 clinical trials statistics guideline. The original ICH guideline (ICH E9) focused on the use of...
Pearl IRB will sponsor IMDMC 2017 Annual Conference
Pearl IRB is excited to attend and sponsor the IMDMC Annual Conference tomorrow, November 1, 2017 at the Montague Banquet Center in Indianapolis. This conference provides an opportunity for networking, collaboration, and discussion of recent news and...
China now accepts clinical trial data from other countries
China announced earlier this month that it will begin accepting clinical trial data from other countries, Outsourcing-Pharma.com reports. The new guideline, issued by the General Office of the Communisty Party of China Central Committee and the General...
Gretchen Bowker will lead a Purdue Foundry Shakeout Session on working with regulatory agencies
Join Gretchen Bowker, co-founder and COO of Pearl IRB, on Wednesday, October 25 2017 for a Purdue Foundry Shakeout Session. The Shakeout Session, which runs from 12:00 - 1:30pm EST, is titled "Working with Regulatory Agencies." Bowker will discuss working...